pyrazinamide has been researched along with Exocrine Pancreatic Insufficiency in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Exocrine Pancreatic Insufficiency: A malabsorption condition resulting from greater than 10% reduction in the secretion of pancreatic digestive enzymes (LIPASE; PROTEASES; and AMYLASE) by the EXOCRINE PANCREAS into the DUODENUM. This condition is often associated with CYSTIC FIBROSIS and with chronic PANCREATITIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rifampin has been reported to cause acute pancreatitis in up to 2." | 1.30 | Pancreatic insufficiency due to antituberculous therapy. ( Cohen, LB; Knowles, SR; Liu, BA; Shear, NH; Werb, MR, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, BA | 1 |
| Knowles, SR | 1 |
| Cohen, LB | 1 |
| Werb, MR | 1 |
| Shear, NH | 1 |
1 other study available for pyrazinamide and Exocrine Pancreatic Insufficiency
| Article | Year |
|---|---|
Pancreatic insufficiency due to antituberculous therapy.
Topics: Antitubercular Agents; Chronic Disease; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol | 1997 |